Previous Close | 198.32 |
Open | 199.88 |
Bid | 193.44 x 1000 |
Ask | 249.50 x 1800 |
Day's Range | 195.99 - 199.88 |
52 Week Range | 182.65 - 276.43 |
Volume | |
Avg. Volume | 283,287 |
Market Cap | 9.23B |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | 25.21 |
EPS (TTM) | 7.79 |
Earnings Date | Oct 25, 2023 - Oct 30, 2023 |
Forward Dividend & Yield | 1.36 (0.69%) |
Ex-Dividend Date | Aug 14, 2023 |
1y Target Est | 263.67 |
Subscribe to Yahoo Finance Plus to view Fair Value for TFX
With respect to Teleflex's (TFX) market development objectives for UroLift, the company witnesses growth for UroLift in the hospital setting.
Teleflex (TFX) gets selected to exhibit Arrow VPS Rhythm DLX Device and Arrow PICCs preloaded with the NaviCurve Stylet at the Vizient Innovative Technology Exchange.
Teleflex's (TFX) survey results highlight how crucial it is for men to consult a urologist if they have strange or troublesome urine symptoms.